The women’s 168澳洲5最新开奖结果:Canyon-Sram team have suspended 168澳洲5最新开奖结果:Shari Bossuyt from racing af😼ter revealing she tested positive for 🗹the banned substance Letrozole.
Letrozole is primarily used to treat estrogen-sensitive cancer in post-menopausal 🤪women. A doping effect can be similar to taking testosterone, which is why it is on WADA's prohibited list.
Fellow Belgian rider 168澳洲5最新开奖结果:Toon Aerts tested positive for the drug🔯 in late 2022. He denied any wrongdoing and refused to accept a two-year suspension but has been unable to prove his case was sparked by contamination.
Bossuyt and her manager will hold a press conference in Belgium on Mon🌳day morning to explain her case.
Letrozole is considered a "specified substance" that does not require a mandatory provisional suspension and so Bossuyt was able to race as her case emerged. She rode Paris-Roubaix Femmes and on thಞe track at the Canada Nations Cup event in late April.
Bossuyt and her manager have told Canyon-Sram that both her A and B samples tested positive for Letrozole and she now𓆏 awaits a final verdict from the French Agence française de lutte contre le dopage (AFLD), who carried out the test on March 19 during the Tour de Normandie Féminin.
Canyon-Sram extended her contract 🐎on April 5 but have now𒈔 put her on ‘provisionally non-active’ status.
“CANYON//SRAM Racing has a zero-tolerance stance towards any use of prohibited substances in accordan♏ce with WADA Anti-Doping Regulations. Adherence to the anti-doping rules is therefore pa💝rt of all contracts between all riders and CANYON//SRAM Racing,” the team said in a statement issued early on Sunday morning.
“In ᩚᩚᩚᩚᩚᩚᩚᩚᩚ𒀱ᩚᩚᩚaccordance with its own anti-doping rules, the team has made Shari provi🃏sionally non-active for CANYON//SRAM Racing. The team is now waiting for the decision of the AFLD before taking any further action.
“We have a clear zero-tolerance st🌼ance towards doping in sport. We are in contact with Shari and her manager and await the decision of the AFLD,” Team manager Ronny Lauke said.
